Global Sustained Release Injectables Market Growth 2020-2025
The report requires updating with new data and is sent in 48 hours after order is placed.
According to this study, over the next five years the Sustained Release Injectables market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Sustained Release Injectables business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Sustained Release Injectables market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Sustained Release Injectables, covering the supply chain analysis, impact assessment to the Sustained Release Injectables market size growth rate in several scenarios, and the measures to be undertaken by Sustained Release Injectables companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Research objectives
According to this study, over the next five years the Sustained Release Injectables market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Sustained Release Injectables business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Sustained Release Injectables market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Sustained Release Injectables, covering the supply chain analysis, impact assessment to the Sustained Release Injectables market size growth rate in several scenarios, and the measures to be undertaken by Sustained Release Injectables companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
- Naltrexone
- Exenatide
- Estradiol
- Other
- Diabetes
- Leukemia
- Acromegaly
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- AstraZeneca
- Critical Pharmaceuticals
- Eli Lilly
- Roche
- Novartis
- Sanofi
- Biomarin
- Aurobindo
- Camurus
- Avadel
- Alkermes
- Taiwan Liposome Company
- Ascendis Pharma
- Amylin
Research objectives
- To study and analyze the global Sustained Release Injectables consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
- To understand the structure of Sustained Release Injectables market by identifying its various subsegments.
- Focuses on the key global Sustained Release Injectables manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
- To analyze the Sustained Release Injectables with respect to individual growth trends, future prospects, and their contribution to the total market.
- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
- To project the consumption of Sustained Release Injectables submarkets, with respect to key regions (along with their respective key countries).
- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
- To strategically profile the key players and comprehensively analyze their growth strategies.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Sustained Release Injectables Consumption 2015-2025
2.1.2 Sustained Release Injectables Consumption CAGR by Region
2.2 Sustained Release Injectables Segment by Type
2.2.1 Naltrexone
2.2.2 Exenatide
2.2.3 Estradiol
2.2.4 Other
2.3 Sustained Release Injectables Consumption by Type
2.3.1 Global Sustained Release Injectables Consumption Market Share by Type (2015-2020)
2.3.2 Global Sustained Release Injectables Revenue and Market Share by Type (2015-2020)
2.3.3 Global Sustained Release Injectables Sale Price by Type (2015-2020)
2.4 Sustained Release Injectables Segment by Application
2.4.1 Diabetes
2.4.2 Leukemia
2.4.3 Acromegaly
2.4.4 Other
2.5 Sustained Release Injectables Consumption by Application
2.5.1 Global Sustained Release Injectables Consumption Market Share by Type (2015-2020)
2.5.2 Global Sustained Release Injectables Value and Market Share by Type (2015-2020)
2.5.3 Global Sustained Release Injectables Sale Price by Type (2015-2020)
3 GLOBAL SUSTAINED RELEASE INJECTABLES BY COMPANY
3.1 Global Sustained Release Injectables Sales Market Share by Company
3.1.1 Global Sustained Release Injectables Sales by Company (2018-2020)
3.1.2 Global Sustained Release Injectables Sales Market Share by Company (2018-2020)
3.2 Global Sustained Release Injectables Revenue Market Share by Company
3.2.1 Global Sustained Release Injectables Revenue by Company (2018-2020)
3.2.2 Global Sustained Release Injectables Revenue Market Share by Company (2018-2020)
3.3 Global Sustained Release Injectables Sale Price by Company
3.4 Global Sustained Release Injectables Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Sustained Release Injectables Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Sustained Release Injectables Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 SUSTAINED RELEASE INJECTABLES BY REGIONS
4.1 Sustained Release Injectables by Regions
4.2 Americas Sustained Release Injectables Consumption Growth
4.3 APAC Sustained Release Injectables Consumption Growth
4.4 Europe Sustained Release Injectables Consumption Growth
4.5 Middle East & Africa Sustained Release Injectables Consumption Growth
5 AMERICAS
5.1 Americas Sustained Release Injectables Consumption by Countries
5.1.1 Americas Sustained Release Injectables Consumption by Countries (2015-2020)
5.1.2 Americas Sustained Release Injectables Value by Countries (2015-2020)
5.2 Americas Sustained Release Injectables Consumption by Type
5.3 Americas Sustained Release Injectables Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Sustained Release Injectables Consumption by Regions
6.1.1 APAC Sustained Release Injectables Consumption by Regions (2015-2020)
6.1.2 APAC Sustained Release Injectables Value by Regions (2015-2020)
6.2 APAC Sustained Release Injectables Consumption by Type
6.3 APAC Sustained Release Injectables Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 EUROPE
7.1 Europe Sustained Release Injectables by Countries
7.1.1 Europe Sustained Release Injectables Consumption by Countries (2015-2020)
7.1.2 Europe Sustained Release Injectables Value by Countries (2015-2020)
7.2 Europe Sustained Release Injectables Consumption by Type
7.3 Europe Sustained Release Injectables Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Sustained Release Injectables by Countries
8.1.1 Middle East & Africa Sustained Release Injectables Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Sustained Release Injectables Value by Countries (2015-2020)
8.2 Middle East & Africa Sustained Release Injectables Consumption by Type
8.3 Middle East & Africa Sustained Release Injectables Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 MARKETING, DISTRIBUTORS AND CUSTOMER
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Sustained Release Injectables Distributors
10.3 Sustained Release Injectables Customer
11 GLOBAL SUSTAINED RELEASE INJECTABLES MARKET FORECAST
11.1 Global Sustained Release Injectables Consumption Forecast (2021-2025)
11.2 Global Sustained Release Injectables Forecast by Regions
11.2.1 Global Sustained Release Injectables Forecast by Regions (2021-2025)
11.2.2 Global Sustained Release Injectables Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Sustained Release Injectables Forecast by Type
11.8 Global Sustained Release Injectables Forecast by Application
12 KEY PLAYERS ANALYSIS
12.1 AstraZeneca
12.1.1 Company Information
12.1.2 Sustained Release Injectables Product Offered
12.1.3 AstraZeneca Sustained Release Injectables Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 AstraZeneca Latest Developments
12.2 Critical Pharmaceuticals
12.2.1 Company Information
12.2.2 Sustained Release Injectables Product Offered
12.2.3 Critical Pharmaceuticals Sustained Release Injectables Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Critical Pharmaceuticals Latest Developments
12.3 Eli Lilly
12.3.1 Company Information
12.3.2 Sustained Release Injectables Product Offered
12.3.3 Eli Lilly Sustained Release Injectables Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Eli Lilly Latest Developments
12.4 Roche
12.4.1 Company Information
12.4.2 Sustained Release Injectables Product Offered
12.4.3 Roche Sustained Release Injectables Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Roche Latest Developments
12.5 Novartis
12.5.1 Company Information
12.5.2 Sustained Release Injectables Product Offered
12.5.3 Novartis Sustained Release Injectables Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Novartis Latest Developments
12.6 Sanofi
12.6.1 Company Information
12.6.2 Sustained Release Injectables Product Offered
12.6.3 Sanofi Sustained Release Injectables Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Sanofi Latest Developments
12.7 Biomarin
12.7.1 Company Information
12.7.2 Sustained Release Injectables Product Offered
12.7.3 Biomarin Sustained Release Injectables Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Biomarin Latest Developments
12.8 Aurobindo
12.8.1 Company Information
12.8.2 Sustained Release Injectables Product Offered
12.8.3 Aurobindo Sustained Release Injectables Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Aurobindo Latest Developments
12.9 Camurus
12.9.1 Company Information
12.9.2 Sustained Release Injectables Product Offered
12.9.3 Camurus Sustained Release Injectables Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Camurus Latest Developments
12.10 Avadel
12.10.1 Company Information
12.10.2 Sustained Release Injectables Product Offered
12.10.3 Avadel Sustained Release Injectables Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Avadel Latest Developments
12.11 Alkermes
12.11.1 Company Information
12.11.2 Sustained Release Injectables Product Offered
12.11.3 Alkermes Sustained Release Injectables Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Alkermes Latest Developments
12.12 Taiwan Liposome Company
12.12.1 Company Information
12.12.2 Sustained Release Injectables Product Offered
12.12.3 Taiwan Liposome Company Sustained Release Injectables Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Taiwan Liposome Company Latest Developments
12.13 Ascendis Pharma
12.13.1 Company Information
12.13.2 Sustained Release Injectables Product Offered
12.13.3 Ascendis Pharma Sustained Release Injectables Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Ascendis Pharma Latest Developments
12.14 Amylin
12.14.1 Company Information
12.14.2 Sustained Release Injectables Product Offered
12.14.3 Amylin Sustained Release Injectables Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 Amylin Latest Developments
13 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Sustained Release Injectables Consumption 2015-2025
2.1.2 Sustained Release Injectables Consumption CAGR by Region
2.2 Sustained Release Injectables Segment by Type
2.2.1 Naltrexone
2.2.2 Exenatide
2.2.3 Estradiol
2.2.4 Other
2.3 Sustained Release Injectables Consumption by Type
2.3.1 Global Sustained Release Injectables Consumption Market Share by Type (2015-2020)
2.3.2 Global Sustained Release Injectables Revenue and Market Share by Type (2015-2020)
2.3.3 Global Sustained Release Injectables Sale Price by Type (2015-2020)
2.4 Sustained Release Injectables Segment by Application
2.4.1 Diabetes
2.4.2 Leukemia
2.4.3 Acromegaly
2.4.4 Other
2.5 Sustained Release Injectables Consumption by Application
2.5.1 Global Sustained Release Injectables Consumption Market Share by Type (2015-2020)
2.5.2 Global Sustained Release Injectables Value and Market Share by Type (2015-2020)
2.5.3 Global Sustained Release Injectables Sale Price by Type (2015-2020)
3 GLOBAL SUSTAINED RELEASE INJECTABLES BY COMPANY
3.1 Global Sustained Release Injectables Sales Market Share by Company
3.1.1 Global Sustained Release Injectables Sales by Company (2018-2020)
3.1.2 Global Sustained Release Injectables Sales Market Share by Company (2018-2020)
3.2 Global Sustained Release Injectables Revenue Market Share by Company
3.2.1 Global Sustained Release Injectables Revenue by Company (2018-2020)
3.2.2 Global Sustained Release Injectables Revenue Market Share by Company (2018-2020)
3.3 Global Sustained Release Injectables Sale Price by Company
3.4 Global Sustained Release Injectables Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Sustained Release Injectables Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Sustained Release Injectables Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 SUSTAINED RELEASE INJECTABLES BY REGIONS
4.1 Sustained Release Injectables by Regions
4.2 Americas Sustained Release Injectables Consumption Growth
4.3 APAC Sustained Release Injectables Consumption Growth
4.4 Europe Sustained Release Injectables Consumption Growth
4.5 Middle East & Africa Sustained Release Injectables Consumption Growth
5 AMERICAS
5.1 Americas Sustained Release Injectables Consumption by Countries
5.1.1 Americas Sustained Release Injectables Consumption by Countries (2015-2020)
5.1.2 Americas Sustained Release Injectables Value by Countries (2015-2020)
5.2 Americas Sustained Release Injectables Consumption by Type
5.3 Americas Sustained Release Injectables Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Sustained Release Injectables Consumption by Regions
6.1.1 APAC Sustained Release Injectables Consumption by Regions (2015-2020)
6.1.2 APAC Sustained Release Injectables Value by Regions (2015-2020)
6.2 APAC Sustained Release Injectables Consumption by Type
6.3 APAC Sustained Release Injectables Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 EUROPE
7.1 Europe Sustained Release Injectables by Countries
7.1.1 Europe Sustained Release Injectables Consumption by Countries (2015-2020)
7.1.2 Europe Sustained Release Injectables Value by Countries (2015-2020)
7.2 Europe Sustained Release Injectables Consumption by Type
7.3 Europe Sustained Release Injectables Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Sustained Release Injectables by Countries
8.1.1 Middle East & Africa Sustained Release Injectables Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Sustained Release Injectables Value by Countries (2015-2020)
8.2 Middle East & Africa Sustained Release Injectables Consumption by Type
8.3 Middle East & Africa Sustained Release Injectables Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 MARKETING, DISTRIBUTORS AND CUSTOMER
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Sustained Release Injectables Distributors
10.3 Sustained Release Injectables Customer
11 GLOBAL SUSTAINED RELEASE INJECTABLES MARKET FORECAST
11.1 Global Sustained Release Injectables Consumption Forecast (2021-2025)
11.2 Global Sustained Release Injectables Forecast by Regions
11.2.1 Global Sustained Release Injectables Forecast by Regions (2021-2025)
11.2.2 Global Sustained Release Injectables Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Sustained Release Injectables Forecast by Type
11.8 Global Sustained Release Injectables Forecast by Application
12 KEY PLAYERS ANALYSIS
12.1 AstraZeneca
12.1.1 Company Information
12.1.2 Sustained Release Injectables Product Offered
12.1.3 AstraZeneca Sustained Release Injectables Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 AstraZeneca Latest Developments
12.2 Critical Pharmaceuticals
12.2.1 Company Information
12.2.2 Sustained Release Injectables Product Offered
12.2.3 Critical Pharmaceuticals Sustained Release Injectables Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Critical Pharmaceuticals Latest Developments
12.3 Eli Lilly
12.3.1 Company Information
12.3.2 Sustained Release Injectables Product Offered
12.3.3 Eli Lilly Sustained Release Injectables Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Eli Lilly Latest Developments
12.4 Roche
12.4.1 Company Information
12.4.2 Sustained Release Injectables Product Offered
12.4.3 Roche Sustained Release Injectables Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Roche Latest Developments
12.5 Novartis
12.5.1 Company Information
12.5.2 Sustained Release Injectables Product Offered
12.5.3 Novartis Sustained Release Injectables Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Novartis Latest Developments
12.6 Sanofi
12.6.1 Company Information
12.6.2 Sustained Release Injectables Product Offered
12.6.3 Sanofi Sustained Release Injectables Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Sanofi Latest Developments
12.7 Biomarin
12.7.1 Company Information
12.7.2 Sustained Release Injectables Product Offered
12.7.3 Biomarin Sustained Release Injectables Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Biomarin Latest Developments
12.8 Aurobindo
12.8.1 Company Information
12.8.2 Sustained Release Injectables Product Offered
12.8.3 Aurobindo Sustained Release Injectables Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Aurobindo Latest Developments
12.9 Camurus
12.9.1 Company Information
12.9.2 Sustained Release Injectables Product Offered
12.9.3 Camurus Sustained Release Injectables Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Camurus Latest Developments
12.10 Avadel
12.10.1 Company Information
12.10.2 Sustained Release Injectables Product Offered
12.10.3 Avadel Sustained Release Injectables Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Avadel Latest Developments
12.11 Alkermes
12.11.1 Company Information
12.11.2 Sustained Release Injectables Product Offered
12.11.3 Alkermes Sustained Release Injectables Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Alkermes Latest Developments
12.12 Taiwan Liposome Company
12.12.1 Company Information
12.12.2 Sustained Release Injectables Product Offered
12.12.3 Taiwan Liposome Company Sustained Release Injectables Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Taiwan Liposome Company Latest Developments
12.13 Ascendis Pharma
12.13.1 Company Information
12.13.2 Sustained Release Injectables Product Offered
12.13.3 Ascendis Pharma Sustained Release Injectables Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Ascendis Pharma Latest Developments
12.14 Amylin
12.14.1 Company Information
12.14.2 Sustained Release Injectables Product Offered
12.14.3 Amylin Sustained Release Injectables Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 Amylin Latest Developments
13 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Research Methodology
Table 2. Data Source
Table 3. Sustained Release Injectables Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Naltrexone
Table 5. Major Players of Exenatide
Table 6. Major Players of Estradiol
Table 7. Major Players of Other
Table 8. Global Consumption Sales by Type (2015-2020)
Table 9. Global Sustained Release Injectables Consumption Market Share by Type (2015-2020)
Table 10. Global Sustained Release Injectables Revenue by Type (2015-2020) ($ million)
Table 11. Global Sustained Release Injectables Value Market Share by Type (2015-2020) ($ Millions)
Table 12. Global Sustained Release Injectables Sale Price by Type (2015-2020)
Table 13. Global Consumption Sales by Application (2015-2020)
Table 14. Global Sustained Release Injectables Consumption Market Share by Application (2015-2020)
Table 15. Global Sustained Release Injectables Value by Application (2015-2020)
Table 16. Global Sustained Release Injectables Value Market Share by Application (2015-2020)
Table 17. Global Sustained Release Injectables Sale Price by Application (2015-2020)
Table 18. Global Sustained Release Injectables Sales by Company (2017-2019) (K Units)
Table 19. Global Sustained Release Injectables Sales Market Share by Company (2017-2019)
Table 20. Global Sustained Release Injectables Revenue by Company (2017-2019) ($ Millions)
Table 21. Global Sustained Release Injectables Revenue Market Share by Company (2017-2019)
Table 22. Global Sustained Release Injectables Sale Price by Company (2017-2019)
Table 23. Global Sustained Release Injectables Manufacturing Base Distribution and Sales Area by Manufacturers
Table 24. Players Sustained Release Injectables Products Offered
Table 25. Sustained Release Injectables Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 26. Global Sustained Release Injectables Consumption by Regions 2015-2020 (K Units)
Table 27. Global Sustained Release Injectables Consumption Market Share by Regions 2015-2020
Table 28. Global Sustained Release Injectables Value by Regions 2015-2020 ($ Millions)
Table 29. Global Sustained Release Injectables Value Market Share by Regions 2015-2020
Table 30. Americas Sustained Release Injectables Consumption by Countries (2015-2020) (K Units)
Table 31. Americas Sustained Release Injectables Consumption Market Share by Countries (2015-2020)
Table 32. Americas Sustained Release Injectables Value by Countries (2015-2020) ($ Millions)
Table 33. Americas Sustained Release Injectables Value Market Share by Countries (2015-2020)
Table 34. Americas Sustained Release Injectables Consumption by Type (2015-2020) (K Units)
Table 35. Americas Sustained Release Injectables Consumption Market Share by Type (2015-2020)
Table 36. Americas Sustained Release Injectables Consumption by Application (2015-2020) (K Units)
Table 37. Americas Sustained Release Injectables Consumption Market Share by Application (2015-2020)
Table 38. APAC Sustained Release Injectables Consumption by Countries (2015-2020) (K Units)
Table 39. APAC Sustained Release Injectables Consumption Market Share by Countries (2015-2020)
Table 40. APAC Sustained Release Injectables Value by Regions (2015-2020) ($ Millions)
Table 41. APAC Sustained Release Injectables Value Market Share by Regions (2015-2020)
Table 42. APAC Sustained Release Injectables Consumption by Type (2015-2020) (K Units)
Table 43. APAC Sustained Release Injectables Consumption Market Share by Type (2015-2020)
Table 44. APAC Sustained Release Injectables Consumption by Application (2015-2020) (K Units)
Table 45. APAC Sustained Release Injectables Consumption Market Share by Application (2015-2020)
Table 46. Europe Sustained Release Injectables Consumption by Countries (2015-2020) (K Units)
Table 47. Europe Sustained Release Injectables Consumption Market Share by Countries (2015-2020)
Table 48. Europe Sustained Release Injectables Value by Countries (2015-2020) ($ Millions)
Table 49. Europe Sustained Release Injectables Value Market Share by Countries (2015-2020)
Table 50. Europe Sustained Release Injectables Consumption by Type (2015-2020) (K Units)
Table 51. Europe Sustained Release Injectables Consumption Market Share by Type (2015-2020)
Table 52. Europe Sustained Release Injectables Consumption by Application (2015-2020) (K Units)
Table 53. Europe Sustained Release Injectables Consumption Market Share by Application (2015-2020)
Table 54. Middle East & Africa Sustained Release Injectables Consumption by Countries (2015-2020) (K Units)
Table 55. Middle East & Africa Sustained Release Injectables Consumption Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Sustained Release Injectables Value by Countries (2015-2020) ($ Millions)
Table 57. Middle East & Africa Sustained Release Injectables Value Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Sustained Release Injectables Consumption by Type (2015-2020) (K Units)
Table 59. Middle East & Africa Sustained Release Injectables Consumption Market Share by Type (2015-2020)
Table 60. Middle East & Africa Sustained Release Injectables Consumption by Application (2015-2020) (K Units)
Table 61. Middle East & Africa Sustained Release Injectables Consumption Market Share by Application (2015-2020)
Table 62. Sustained Release Injectables Distributors List
Table 63. Sustained Release Injectables Customer List
Table 64. Global Sustained Release Injectables Consumption Forecast by Countries (2021-2025) (K Units)
Table 65. Global Sustained Release Injectables Consumption Market Forecast by Regions
Table 66. Global Sustained Release Injectables Value Forecast by Countries (2021-2025) ($ Millions)
Table 67. Global Sustained Release Injectables Value Market Share Forecast by Regions
Table 68. Global Sustained Release Injectables Consumption Forecast by Type (2021-2025) (K Units)
Table 69. Global Sustained Release Injectables Consumption Market Share Forecast by Type (2021-2025)
Table 70. Global Sustained Release Injectables Value Forecast by Type (2021-2025) ($ Millions)
Table 71. Global Sustained Release Injectables Value Market Share Forecast by Type (2021-2025)
Table 72. Global Sustained Release Injectables Consumption Forecast by Application (2021-2025) (K Units)
Table 73. Global Sustained Release Injectables Consumption Market Share Forecast by Application (2021-2025)
Table 74. Global Sustained Release Injectables Value Forecast by Application (2021-2025) ($ Millions)
Table 75. Global Sustained Release Injectables Value Market Share Forecast by Application (2021-2025)
Table 76. AstraZeneca Product Offered
Table 77. AstraZeneca Sustained Release Injectables Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 78. AstraZeneca Main Business
Table 79. AstraZeneca Latest Developments
Table 80. AstraZeneca Basic Information, Company Total Revenue (in $ million), Sustained Release Injectables Manufacturing Base, Sales Area and Its Competitors
Table 81. Critical Pharmaceuticals Product Offered
Table 82. Critical Pharmaceuticals Sustained Release Injectables Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 83. Critical Pharmaceuticals Main Business
Table 84. Critical Pharmaceuticals Latest Developments
Table 85. Critical Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Sustained Release Injectables Manufacturing Base, Sales Area and Its Competitors
Table 86. Eli Lilly Product Offered
Table 87. Eli Lilly Sustained Release Injectables Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 88. Eli Lilly Main Business
Table 89. Eli Lilly Latest Developments
Table 90. Eli Lilly Basic Information, Company Total Revenue (in $ million), Sustained Release Injectables Manufacturing Base, Sales Area and Its Competitors
Table 91. Roche Product Offered
Table 92. Roche Sustained Release Injectables Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 93. Roche Main Business
Table 94. Roche Latest Developments
Table 95. Roche Basic Information, Company Total Revenue (in $ million), Sustained Release Injectables Manufacturing Base, Sales Area and Its Competitors
Table 96. Novartis Product Offered
Table 97. Novartis Sustained Release Injectables Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 98. Novartis Main Business
Table 99. Novartis Latest Developments
Table 100. Novartis Basic Information, Company Total Revenue (in $ million), Sustained Release Injectables Manufacturing Base, Sales Area and Its Competitors
Table 101. Sanofi Product Offered
Table 102. Sanofi Sustained Release Injectables Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 103. Sanofi Main Business
Table 104. Sanofi Latest Developments
Table 105. Sanofi Basic Information, Company Total Revenue (in $ million), Sustained Release Injectables Manufacturing Base, Sales Area and Its Competitors
Table 106. Biomarin Product Offered
Table 107. Biomarin Basic Information, Company Total Revenue (in $ million), Sustained Release Injectables Manufacturing Base, Sales Area and Its Competitors
Table 108. Biomarin Main Business
Table 109. Biomarin Latest Developments
Table 110. Biomarin Sustained Release Injectables Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 111. Aurobindo Product Offered
Table 112. Aurobindo Sustained Release Injectables Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 113. Aurobindo Main Business
Table 114. Aurobindo Latest Developments
Table 115. Aurobindo Basic Information, Company Total Revenue (in $ million), Sustained Release Injectables Manufacturing Base, Sales Area and Its Competitors
Table 116. Camurus Product Offered
Table 117. Camurus Sustained Release Injectables Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 118. Camurus Main Business
Table 119. Camurus Latest Developments
Table 120. Camurus Basic Information, Company Total Revenue (in $ million), Sustained Release Injectables Manufacturing Base, Sales Area and Its Competitors
Table 121. Avadel Product Offered
Table 122. Avadel Sustained Release Injectables Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 123. Avadel Main Business
Table 124. Avadel Latest Developments
Table 125. Avadel Basic Information, Company Total Revenue (in $ million), Sustained Release Injectables Manufacturing Base, Sales Area and Its Competitors
Table 126. Alkermes Product Offered
Table 127. Alkermes Sustained Release Injectables Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 128. Alkermes Main Business
Table 129. Alkermes Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 130. Alkermes Latest Developments
Table 131. Taiwan Liposome Company Product Offered
Table 132. Taiwan Liposome Company Sustained Release Injectables Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 133. Taiwan Liposome Company Main Business
Table 134. Taiwan Liposome Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 135. Taiwan Liposome Company Latest Developments
Table 136. Ascendis Pharma Product Offered
Table 137. Ascendis Pharma Sustained Release Injectables Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 138. Ascendis Pharma Main Business
Table 139. Ascendis Pharma Latest Developments
Table 140. Ascendis Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 141. Amylin Product Offered
Table 142. Amylin Sustained Release Injectables Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 143. Amylin Main Business
Table 144. Amylin Latest Developments
Table 145. Amylin Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 1. Research Methodology
Table 2. Data Source
Table 3. Sustained Release Injectables Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Naltrexone
Table 5. Major Players of Exenatide
Table 6. Major Players of Estradiol
Table 7. Major Players of Other
Table 8. Global Consumption Sales by Type (2015-2020)
Table 9. Global Sustained Release Injectables Consumption Market Share by Type (2015-2020)
Table 10. Global Sustained Release Injectables Revenue by Type (2015-2020) ($ million)
Table 11. Global Sustained Release Injectables Value Market Share by Type (2015-2020) ($ Millions)
Table 12. Global Sustained Release Injectables Sale Price by Type (2015-2020)
Table 13. Global Consumption Sales by Application (2015-2020)
Table 14. Global Sustained Release Injectables Consumption Market Share by Application (2015-2020)
Table 15. Global Sustained Release Injectables Value by Application (2015-2020)
Table 16. Global Sustained Release Injectables Value Market Share by Application (2015-2020)
Table 17. Global Sustained Release Injectables Sale Price by Application (2015-2020)
Table 18. Global Sustained Release Injectables Sales by Company (2017-2019) (K Units)
Table 19. Global Sustained Release Injectables Sales Market Share by Company (2017-2019)
Table 20. Global Sustained Release Injectables Revenue by Company (2017-2019) ($ Millions)
Table 21. Global Sustained Release Injectables Revenue Market Share by Company (2017-2019)
Table 22. Global Sustained Release Injectables Sale Price by Company (2017-2019)
Table 23. Global Sustained Release Injectables Manufacturing Base Distribution and Sales Area by Manufacturers
Table 24. Players Sustained Release Injectables Products Offered
Table 25. Sustained Release Injectables Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 26. Global Sustained Release Injectables Consumption by Regions 2015-2020 (K Units)
Table 27. Global Sustained Release Injectables Consumption Market Share by Regions 2015-2020
Table 28. Global Sustained Release Injectables Value by Regions 2015-2020 ($ Millions)
Table 29. Global Sustained Release Injectables Value Market Share by Regions 2015-2020
Table 30. Americas Sustained Release Injectables Consumption by Countries (2015-2020) (K Units)
Table 31. Americas Sustained Release Injectables Consumption Market Share by Countries (2015-2020)
Table 32. Americas Sustained Release Injectables Value by Countries (2015-2020) ($ Millions)
Table 33. Americas Sustained Release Injectables Value Market Share by Countries (2015-2020)
Table 34. Americas Sustained Release Injectables Consumption by Type (2015-2020) (K Units)
Table 35. Americas Sustained Release Injectables Consumption Market Share by Type (2015-2020)
Table 36. Americas Sustained Release Injectables Consumption by Application (2015-2020) (K Units)
Table 37. Americas Sustained Release Injectables Consumption Market Share by Application (2015-2020)
Table 38. APAC Sustained Release Injectables Consumption by Countries (2015-2020) (K Units)
Table 39. APAC Sustained Release Injectables Consumption Market Share by Countries (2015-2020)
Table 40. APAC Sustained Release Injectables Value by Regions (2015-2020) ($ Millions)
Table 41. APAC Sustained Release Injectables Value Market Share by Regions (2015-2020)
Table 42. APAC Sustained Release Injectables Consumption by Type (2015-2020) (K Units)
Table 43. APAC Sustained Release Injectables Consumption Market Share by Type (2015-2020)
Table 44. APAC Sustained Release Injectables Consumption by Application (2015-2020) (K Units)
Table 45. APAC Sustained Release Injectables Consumption Market Share by Application (2015-2020)
Table 46. Europe Sustained Release Injectables Consumption by Countries (2015-2020) (K Units)
Table 47. Europe Sustained Release Injectables Consumption Market Share by Countries (2015-2020)
Table 48. Europe Sustained Release Injectables Value by Countries (2015-2020) ($ Millions)
Table 49. Europe Sustained Release Injectables Value Market Share by Countries (2015-2020)
Table 50. Europe Sustained Release Injectables Consumption by Type (2015-2020) (K Units)
Table 51. Europe Sustained Release Injectables Consumption Market Share by Type (2015-2020)
Table 52. Europe Sustained Release Injectables Consumption by Application (2015-2020) (K Units)
Table 53. Europe Sustained Release Injectables Consumption Market Share by Application (2015-2020)
Table 54. Middle East & Africa Sustained Release Injectables Consumption by Countries (2015-2020) (K Units)
Table 55. Middle East & Africa Sustained Release Injectables Consumption Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Sustained Release Injectables Value by Countries (2015-2020) ($ Millions)
Table 57. Middle East & Africa Sustained Release Injectables Value Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Sustained Release Injectables Consumption by Type (2015-2020) (K Units)
Table 59. Middle East & Africa Sustained Release Injectables Consumption Market Share by Type (2015-2020)
Table 60. Middle East & Africa Sustained Release Injectables Consumption by Application (2015-2020) (K Units)
Table 61. Middle East & Africa Sustained Release Injectables Consumption Market Share by Application (2015-2020)
Table 62. Sustained Release Injectables Distributors List
Table 63. Sustained Release Injectables Customer List
Table 64. Global Sustained Release Injectables Consumption Forecast by Countries (2021-2025) (K Units)
Table 65. Global Sustained Release Injectables Consumption Market Forecast by Regions
Table 66. Global Sustained Release Injectables Value Forecast by Countries (2021-2025) ($ Millions)
Table 67. Global Sustained Release Injectables Value Market Share Forecast by Regions
Table 68. Global Sustained Release Injectables Consumption Forecast by Type (2021-2025) (K Units)
Table 69. Global Sustained Release Injectables Consumption Market Share Forecast by Type (2021-2025)
Table 70. Global Sustained Release Injectables Value Forecast by Type (2021-2025) ($ Millions)
Table 71. Global Sustained Release Injectables Value Market Share Forecast by Type (2021-2025)
Table 72. Global Sustained Release Injectables Consumption Forecast by Application (2021-2025) (K Units)
Table 73. Global Sustained Release Injectables Consumption Market Share Forecast by Application (2021-2025)
Table 74. Global Sustained Release Injectables Value Forecast by Application (2021-2025) ($ Millions)
Table 75. Global Sustained Release Injectables Value Market Share Forecast by Application (2021-2025)
Table 76. AstraZeneca Product Offered
Table 77. AstraZeneca Sustained Release Injectables Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 78. AstraZeneca Main Business
Table 79. AstraZeneca Latest Developments
Table 80. AstraZeneca Basic Information, Company Total Revenue (in $ million), Sustained Release Injectables Manufacturing Base, Sales Area and Its Competitors
Table 81. Critical Pharmaceuticals Product Offered
Table 82. Critical Pharmaceuticals Sustained Release Injectables Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 83. Critical Pharmaceuticals Main Business
Table 84. Critical Pharmaceuticals Latest Developments
Table 85. Critical Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Sustained Release Injectables Manufacturing Base, Sales Area and Its Competitors
Table 86. Eli Lilly Product Offered
Table 87. Eli Lilly Sustained Release Injectables Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 88. Eli Lilly Main Business
Table 89. Eli Lilly Latest Developments
Table 90. Eli Lilly Basic Information, Company Total Revenue (in $ million), Sustained Release Injectables Manufacturing Base, Sales Area and Its Competitors
Table 91. Roche Product Offered
Table 92. Roche Sustained Release Injectables Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 93. Roche Main Business
Table 94. Roche Latest Developments
Table 95. Roche Basic Information, Company Total Revenue (in $ million), Sustained Release Injectables Manufacturing Base, Sales Area and Its Competitors
Table 96. Novartis Product Offered
Table 97. Novartis Sustained Release Injectables Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 98. Novartis Main Business
Table 99. Novartis Latest Developments
Table 100. Novartis Basic Information, Company Total Revenue (in $ million), Sustained Release Injectables Manufacturing Base, Sales Area and Its Competitors
Table 101. Sanofi Product Offered
Table 102. Sanofi Sustained Release Injectables Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 103. Sanofi Main Business
Table 104. Sanofi Latest Developments
Table 105. Sanofi Basic Information, Company Total Revenue (in $ million), Sustained Release Injectables Manufacturing Base, Sales Area and Its Competitors
Table 106. Biomarin Product Offered
Table 107. Biomarin Basic Information, Company Total Revenue (in $ million), Sustained Release Injectables Manufacturing Base, Sales Area and Its Competitors
Table 108. Biomarin Main Business
Table 109. Biomarin Latest Developments
Table 110. Biomarin Sustained Release Injectables Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 111. Aurobindo Product Offered
Table 112. Aurobindo Sustained Release Injectables Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 113. Aurobindo Main Business
Table 114. Aurobindo Latest Developments
Table 115. Aurobindo Basic Information, Company Total Revenue (in $ million), Sustained Release Injectables Manufacturing Base, Sales Area and Its Competitors
Table 116. Camurus Product Offered
Table 117. Camurus Sustained Release Injectables Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 118. Camurus Main Business
Table 119. Camurus Latest Developments
Table 120. Camurus Basic Information, Company Total Revenue (in $ million), Sustained Release Injectables Manufacturing Base, Sales Area and Its Competitors
Table 121. Avadel Product Offered
Table 122. Avadel Sustained Release Injectables Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 123. Avadel Main Business
Table 124. Avadel Latest Developments
Table 125. Avadel Basic Information, Company Total Revenue (in $ million), Sustained Release Injectables Manufacturing Base, Sales Area and Its Competitors
Table 126. Alkermes Product Offered
Table 127. Alkermes Sustained Release Injectables Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 128. Alkermes Main Business
Table 129. Alkermes Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 130. Alkermes Latest Developments
Table 131. Taiwan Liposome Company Product Offered
Table 132. Taiwan Liposome Company Sustained Release Injectables Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 133. Taiwan Liposome Company Main Business
Table 134. Taiwan Liposome Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 135. Taiwan Liposome Company Latest Developments
Table 136. Ascendis Pharma Product Offered
Table 137. Ascendis Pharma Sustained Release Injectables Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 138. Ascendis Pharma Main Business
Table 139. Ascendis Pharma Latest Developments
Table 140. Ascendis Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 141. Amylin Product Offered
Table 142. Amylin Sustained Release Injectables Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 143. Amylin Main Business
Table 144. Amylin Latest Developments
Table 145. Amylin Basic Information, Manufacturing Base, Sales Area and Its Competitors
LIST OF FIGURES
Figure 1. Picture of Sustained Release Injectables
Figure 2. Sustained Release Injectables Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Sustained Release Injectables Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Sustained Release Injectables Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Naltrexone
Figure 7. Product Picture of Exenatide
Figure 8. Product Picture of Estradiol
Figure 9. Product Picture of Other
Figure 10. Global Sustained Release Injectables Consumption Market Share by Type (2015-2020)
Figure 11. Global Sustained Release Injectables Value Market Share by Type (2015-2020)
Figure 12. Sustained Release Injectables Consumed in Diabetes
Figure 13. Global Sustained Release Injectables Market: Diabetes (2015-2020) (K Units)
Figure 14. Global Sustained Release Injectables Market: Diabetes (2015-2020) ($ Millions)
Figure 15. Sustained Release Injectables Consumed in Leukemia
Figure 16. Global Sustained Release Injectables Market: Leukemia (2015-2020) (K Units)
Figure 17. Global Sustained Release Injectables Market: Leukemia (2015-2020) ($ Millions)
Figure 18. Sustained Release Injectables Consumed in Acromegaly
Figure 19. Global Sustained Release Injectables Market: Acromegaly (2015-2020) (K Units)
Figure 20. Global Sustained Release Injectables Market: Acromegaly (2015-2020) ($ Millions)
Figure 21. Sustained Release Injectables Consumed in Other
Figure 22. Global Sustained Release Injectables Market: Other (2015-2020) (K Units)
Figure 23. Global Sustained Release Injectables Market: Other (2015-2020) ($ Millions)
Figure 24. Global Sustained Release Injectables Consumption Market Share by Application (2015-2020)
Figure 25. Global Sustained Release Injectables Value Market Share by Application (2015-2020)
Figure 26. Global Sustained Release Injectables Sales Market Share by Company in 2017
Figure 27. Global Sustained Release Injectables Sales Market Share by Company in 2019
Figure 28. Global Sustained Release Injectables Revenue Market Share by Company in 2017
Figure 29. Global Sustained Release Injectables Revenue Market Share by Company in 2019
Figure 30. Global Sustained Release Injectables Sale Price by Company in 2019
Figure 31. Global Sustained Release Injectables Consumption Market Share by Regions 2015-2020
Figure 32. Global Sustained Release Injectables Value Market Share by Regions 2015-2020
Figure 33. Americas Sustained Release Injectables Consumption 2015-2020 (K Units)
Figure 34. Americas Sustained Release Injectables Value 2015-2020 ($ Millions)
Figure 35. APAC Sustained Release Injectables Consumption 2015-2020 (K Units)
Figure 36. APAC Sustained Release Injectables Value 2015-2020 ($ Millions)
Figure 37. Europe Sustained Release Injectables Consumption 2015-2020 (K Units)
Figure 38. Europe Sustained Release Injectables Value 2015-2020 ($ Millions)
Figure 39. Middle East & Africa Sustained Release Injectables Consumption 2015-2020 (K Units)
Figure 40. Middle East & Africa Sustained Release Injectables Value 2015-2020 ($ Millions)
Figure 41. Americas Sustained Release Injectables Consumption Market Share by Countries in 2019
Figure 42. Americas Sustained Release Injectables Value Market Share by Countries in 2019
Figure 43. Americas Sustained Release Injectables Consumption Market Share by Type in 2019
Figure 44. Americas Sustained Release Injectables Consumption Market Share by Application in 2019
Figure 45. United States Sustained Release Injectables Consumption Growth 2015-2020 (K Units)
Figure 46. United States Sustained Release Injectables Value Growth 2015-2020 ($ Millions)
Figure 47. Canada Sustained Release Injectables Consumption Growth 2015-2020 (K Units)
Figure 48. Canada Sustained Release Injectables Value Growth 2015-2020 ($ Millions)
Figure 49. Mexico Sustained Release Injectables Consumption Growth 2015-2020 (K Units)
Figure 50. Mexico Sustained Release Injectables Value Growth 2015-2020 ($ Millions)
Figure 51. APAC Sustained Release Injectables Consumption Market Share by Countries in 2019
Figure 52. APAC Sustained Release Injectables Value Market Share by Regions in 2019
Figure 53. APAC Sustained Release Injectables Consumption Market Share by Type in 2019
Figure 54. APAC Sustained Release Injectables Consumption Market Share by Application in 2019
Figure 55. China Sustained Release Injectables Consumption Growth 2015-2020 (K Units)
Figure 56. China Sustained Release Injectables Value Growth 2015-2020 ($ Millions)
Figure 57. Japan Sustained Release Injectables Consumption Growth 2015-2020 (K Units)
Figure 58. Japan Sustained Release Injectables Value Growth 2015-2020 ($ Millions)
Figure 59. Korea Sustained Release Injectables Consumption Growth 2015-2020 (K Units)
Figure 60. Korea Sustained Release Injectables Value Growth 2015-2020 ($ Millions)
Figure 61. Southeast Asia Sustained Release Injectables Consumption Growth 2015-2020 (K Units)
Figure 62. Southeast Asia Sustained Release Injectables Value Growth 2015-2020 ($ Millions)
Figure 63. India Sustained Release Injectables Consumption Growth 2015-2020 (K Units)
Figure 64. India Sustained Release Injectables Value Growth 2015-2020 ($ Millions)
Figure 65. Australia Sustained Release Injectables Consumption Growth 2015-2020 (K Units)
Figure 66. Australia Sustained Release Injectables Value Growth 2015-2020 ($ Millions)
Figure 67. Europe Sustained Release Injectables Consumption Market Share by Countries in 2019
Figure 68. Europe Sustained Release Injectables Value Market Share by Countries in 2019
Figure 69. Europe Sustained Release Injectables Consumption Market Share by Type in 2019
Figure 70. Europe Sustained Release Injectables Consumption Market Share by Application in 2019
Figure 71. Germany Sustained Release Injectables Consumption Growth 2015-2020 (K Units)
Figure 72. Germany Sustained Release Injectables Value Growth 2015-2020 ($ Millions)
Figure 73. France Sustained Release Injectables Consumption Growth 2015-2020 (K Units)
Figure 74. France Sustained Release Injectables Value Growth 2015-2020 ($ Millions)
Figure 75. UK Sustained Release Injectables Consumption Growth 2015-2020 (K Units)
Figure 76. UK Sustained Release Injectables Value Growth 2015-2020 ($ Millions)
Figure 77. Italy Sustained Release Injectables Consumption Growth 2015-2020 (K Units)
Figure 78. Italy Sustained Release Injectables Value Growth 2015-2020 ($ Millions)
Figure 79. Russia Sustained Release Injectables Consumption Growth 2015-2020 (K Units)
Figure 80. Russia Sustained Release Injectables Value Growth 2015-2020 ($ Millions)
Figure 81. Middle East & Africa Sustained Release Injectables Consumption Market Share by Countries in 2019
Figure 82. Middle East & Africa Sustained Release Injectables Value Market Share by Countries in 2019
Figure 83. Middle East & Africa Sustained Release Injectables Consumption Market Share by Type in 2019
Figure 84. Middle East & Africa Sustained Release Injectables Consumption Market Share by Application in 2019
Figure 85. Egypt Sustained Release Injectables Consumption Growth 2015-2020 (K Units)
Figure 86. Egypt Sustained Release Injectables Value Growth 2015-2020 ($ Millions)
Figure 87. South Africa Sustained Release Injectables Consumption Growth 2015-2020 (K Units)
Figure 88. South Africa Sustained Release Injectables Value Growth 2015-2020 ($ Millions)
Figure 89. Israel Sustained Release Injectables Consumption Growth 2015-2020 (K Units)
Figure 90. Israel Sustained Release Injectables Value Growth 2015-2020 ($ Millions)
Figure 91. Turkey Sustained Release Injectables Consumption Growth 2015-2020 (K Units)
Figure 92. Turkey Sustained Release Injectables Value Growth 2015-2020 ($ Millions)
Figure 93. GCC Countries Sustained Release Injectables Consumption Growth 2015-2020 (K Units)
Figure 94. GCC Countries Sustained Release Injectables Value Growth 2015-2020 ($ Millions)
Figure 95. Global Sustained Release Injectables Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 96. Global Sustained Release Injectables Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 97. Americas Sustained Release Injectables Consumption 2021-2025 (K Units)
Figure 98. Americas Sustained Release Injectables Value 2021-2025 ($ Millions)
Figure 99. APAC Sustained Release Injectables Consumption 2021-2025 (K Units)
Figure 100. APAC Sustained Release Injectables Value 2021-2025 ($ Millions)
Figure 101. Europe Sustained Release Injectables Consumption 2021-2025 (K Units)
Figure 102. Europe Sustained Release Injectables Value 2021-2025 ($ Millions)
Figure 103. Middle East & Africa Sustained Release Injectables Consumption 2021-2025 (K Units)
Figure 104. Middle East & Africa Sustained Release Injectables Value 2021-2025 ($ Millions)
Figure 105. United States Sustained Release Injectables Consumption 2021-2025 (K Units)
Figure 106. United States Sustained Release Injectables Value 2021-2025 ($ Millions)
Figure 107. Canada Sustained Release Injectables Consumption 2021-2025 (K Units)
Figure 108. Canada Sustained Release Injectables Value 2021-2025 ($ Millions)
Figure 109. Mexico Sustained Release Injectables Consumption 2021-2025 (K Units)
Figure 110. Mexico Sustained Release Injectables Value 2021-2025 ($ Millions)
Figure 111. Brazil Sustained Release Injectables Consumption 2021-2025 (K Units)
Figure 112. Brazil Sustained Release Injectables Value 2021-2025 ($ Millions)
Figure 113. China Sustained Release Injectables Consumption 2021-2025 (K Units)
Figure 114. China Sustained Release Injectables Value 2021-2025 ($ Millions)
Figure 115. Japan Sustained Release Injectables Consumption 2021-2025 (K Units)
Figure 116. Japan Sustained Release Injectables Value 2021-2025 ($ Millions)
Figure 117. Korea Sustained Release Injectables Consumption 2021-2025 (K Units)
Figure 118. Korea Sustained Release Injectables Value 2021-2025 ($ Millions)
Figure 119. Southeast Asia Sustained Release Injectables Consumption 2021-2025 (K Units)
Figure 120. Southeast Asia Sustained Release Injectables Value 2021-2025 ($ Millions)
Figure 121. India Sustained Release Injectables Consumption 2021-2025 (K Units)
Figure 122. India Sustained Release Injectables Value 2021-2025 ($ Millions)
Figure 123. Australia Sustained Release Injectables Consumption 2021-2025 (K Units)
Figure 124. Australia Sustained Release Injectables Value 2021-2025 ($ Millions)
Figure 125. Germany Sustained Release Injectables Consumption 2021-2025 (K Units)
Figure 126. Germany Sustained Release Injectables Value 2021-2025 ($ Millions)
Figure 127. France Sustained Release Injectables Consumption 2021-2025 (K Units)
Figure 128. France Sustained Release Injectables Value 2021-2025 ($ Millions)
Figure 129. UK Sustained Release Injectables Consumption 2021-2025 (K Units)
Figure 130. UK Sustained Release Injectables Value 2021-2025 ($ Millions)
Figure 131. Italy Sustained Release Injectables Consumption 2021-2025 (K Units)
Figure 132. Italy Sustained Release Injectables Value 2021-2025 ($ Millions)
Figure 133. Russia Sustained Release Injectables Consumption 2021-2025 (K Units)
Figure 134. Russia Sustained Release Injectables Value 2021-2025 ($ Millions)
Figure 135. Spain Sustained Release Injectables Consumption 2021-2025 (K Units)
Figure 136. Spain Sustained Release Injectables Value 2021-2025 ($ Millions)
Figure 137. Egypt Sustained Release Injectables Consumption 2021-2025 (K Units)
Figure 138. Egypt Sustained Release Injectables Value 2021-2025 ($ Millions)
Figure 139. South Africa Sustained Release Injectables Consumption 2021-2025 (K Units)
Figure 140. South Africa Sustained Release Injectables Value 2021-2025 ($ Millions)
Figure 141. Israel Sustained Release Injectables Consumption 2021-2025 (K Units)
Figure 142. Israel Sustained Release Injectables Value 2021-2025 ($ Millions)
Figure 143. Turkey Sustained Release Injectables Consumption 2021-2025 (K Units)
Figure 144. Turkey Sustained Release Injectables Value 2021-2025 ($ Millions)
Figure 145. GCC Countries Sustained Release Injectables Consumption 2021-2025 (K Units)
Figure 146. GCC Countries Sustained Release Injectables Value 2021-2025 ($ Millions)
Figure 147. AstraZeneca Sustained Release Injectables Market Share (2018-2020)
Figure 148. Critical Pharmaceuticals Sustained Release Injectables Market Share (2018-2020)
Figure 149. Eli Lilly Sustained Release Injectables Market Share (2018-2020)
Figure 150. Roche Sustained Release Injectables Market Share (2018-2020)
Figure 151. Novartis Sustained Release Injectables Market Share (2018-2020)
Figure 152. Sanofi Sustained Release Injectables Market Share (2018-2020)
Figure 153. Biomarin Sustained Release Injectables Market Share (2018-2020)
Figure 154. Aurobindo Sustained Release Injectables Market Share (2018-2020)
Figure 155. Camurus Sustained Release Injectables Market Share (2018-2020)
Figure 156. Avadel Sustained Release Injectables Market Share (2018-2020)
Figure 157. Alkermes Sustained Release Injectables Market Share (2018-2020)
Figure 158. Taiwan Liposome Company Sustained Release Injectables Market Share (2018-2020)
Figure 159. Ascendis Pharma Sustained Release Injectables Market Share (2018-2020)
Figure 160. Amylin Sustained Release Injectables Market Share (2018-2020)
Figure 1. Picture of Sustained Release Injectables
Figure 2. Sustained Release Injectables Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Sustained Release Injectables Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Sustained Release Injectables Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Naltrexone
Figure 7. Product Picture of Exenatide
Figure 8. Product Picture of Estradiol
Figure 9. Product Picture of Other
Figure 10. Global Sustained Release Injectables Consumption Market Share by Type (2015-2020)
Figure 11. Global Sustained Release Injectables Value Market Share by Type (2015-2020)
Figure 12. Sustained Release Injectables Consumed in Diabetes
Figure 13. Global Sustained Release Injectables Market: Diabetes (2015-2020) (K Units)
Figure 14. Global Sustained Release Injectables Market: Diabetes (2015-2020) ($ Millions)
Figure 15. Sustained Release Injectables Consumed in Leukemia
Figure 16. Global Sustained Release Injectables Market: Leukemia (2015-2020) (K Units)
Figure 17. Global Sustained Release Injectables Market: Leukemia (2015-2020) ($ Millions)
Figure 18. Sustained Release Injectables Consumed in Acromegaly
Figure 19. Global Sustained Release Injectables Market: Acromegaly (2015-2020) (K Units)
Figure 20. Global Sustained Release Injectables Market: Acromegaly (2015-2020) ($ Millions)
Figure 21. Sustained Release Injectables Consumed in Other
Figure 22. Global Sustained Release Injectables Market: Other (2015-2020) (K Units)
Figure 23. Global Sustained Release Injectables Market: Other (2015-2020) ($ Millions)
Figure 24. Global Sustained Release Injectables Consumption Market Share by Application (2015-2020)
Figure 25. Global Sustained Release Injectables Value Market Share by Application (2015-2020)
Figure 26. Global Sustained Release Injectables Sales Market Share by Company in 2017
Figure 27. Global Sustained Release Injectables Sales Market Share by Company in 2019
Figure 28. Global Sustained Release Injectables Revenue Market Share by Company in 2017
Figure 29. Global Sustained Release Injectables Revenue Market Share by Company in 2019
Figure 30. Global Sustained Release Injectables Sale Price by Company in 2019
Figure 31. Global Sustained Release Injectables Consumption Market Share by Regions 2015-2020
Figure 32. Global Sustained Release Injectables Value Market Share by Regions 2015-2020
Figure 33. Americas Sustained Release Injectables Consumption 2015-2020 (K Units)
Figure 34. Americas Sustained Release Injectables Value 2015-2020 ($ Millions)
Figure 35. APAC Sustained Release Injectables Consumption 2015-2020 (K Units)
Figure 36. APAC Sustained Release Injectables Value 2015-2020 ($ Millions)
Figure 37. Europe Sustained Release Injectables Consumption 2015-2020 (K Units)
Figure 38. Europe Sustained Release Injectables Value 2015-2020 ($ Millions)
Figure 39. Middle East & Africa Sustained Release Injectables Consumption 2015-2020 (K Units)
Figure 40. Middle East & Africa Sustained Release Injectables Value 2015-2020 ($ Millions)
Figure 41. Americas Sustained Release Injectables Consumption Market Share by Countries in 2019
Figure 42. Americas Sustained Release Injectables Value Market Share by Countries in 2019
Figure 43. Americas Sustained Release Injectables Consumption Market Share by Type in 2019
Figure 44. Americas Sustained Release Injectables Consumption Market Share by Application in 2019
Figure 45. United States Sustained Release Injectables Consumption Growth 2015-2020 (K Units)
Figure 46. United States Sustained Release Injectables Value Growth 2015-2020 ($ Millions)
Figure 47. Canada Sustained Release Injectables Consumption Growth 2015-2020 (K Units)
Figure 48. Canada Sustained Release Injectables Value Growth 2015-2020 ($ Millions)
Figure 49. Mexico Sustained Release Injectables Consumption Growth 2015-2020 (K Units)
Figure 50. Mexico Sustained Release Injectables Value Growth 2015-2020 ($ Millions)
Figure 51. APAC Sustained Release Injectables Consumption Market Share by Countries in 2019
Figure 52. APAC Sustained Release Injectables Value Market Share by Regions in 2019
Figure 53. APAC Sustained Release Injectables Consumption Market Share by Type in 2019
Figure 54. APAC Sustained Release Injectables Consumption Market Share by Application in 2019
Figure 55. China Sustained Release Injectables Consumption Growth 2015-2020 (K Units)
Figure 56. China Sustained Release Injectables Value Growth 2015-2020 ($ Millions)
Figure 57. Japan Sustained Release Injectables Consumption Growth 2015-2020 (K Units)
Figure 58. Japan Sustained Release Injectables Value Growth 2015-2020 ($ Millions)
Figure 59. Korea Sustained Release Injectables Consumption Growth 2015-2020 (K Units)
Figure 60. Korea Sustained Release Injectables Value Growth 2015-2020 ($ Millions)
Figure 61. Southeast Asia Sustained Release Injectables Consumption Growth 2015-2020 (K Units)
Figure 62. Southeast Asia Sustained Release Injectables Value Growth 2015-2020 ($ Millions)
Figure 63. India Sustained Release Injectables Consumption Growth 2015-2020 (K Units)
Figure 64. India Sustained Release Injectables Value Growth 2015-2020 ($ Millions)
Figure 65. Australia Sustained Release Injectables Consumption Growth 2015-2020 (K Units)
Figure 66. Australia Sustained Release Injectables Value Growth 2015-2020 ($ Millions)
Figure 67. Europe Sustained Release Injectables Consumption Market Share by Countries in 2019
Figure 68. Europe Sustained Release Injectables Value Market Share by Countries in 2019
Figure 69. Europe Sustained Release Injectables Consumption Market Share by Type in 2019
Figure 70. Europe Sustained Release Injectables Consumption Market Share by Application in 2019
Figure 71. Germany Sustained Release Injectables Consumption Growth 2015-2020 (K Units)
Figure 72. Germany Sustained Release Injectables Value Growth 2015-2020 ($ Millions)
Figure 73. France Sustained Release Injectables Consumption Growth 2015-2020 (K Units)
Figure 74. France Sustained Release Injectables Value Growth 2015-2020 ($ Millions)
Figure 75. UK Sustained Release Injectables Consumption Growth 2015-2020 (K Units)
Figure 76. UK Sustained Release Injectables Value Growth 2015-2020 ($ Millions)
Figure 77. Italy Sustained Release Injectables Consumption Growth 2015-2020 (K Units)
Figure 78. Italy Sustained Release Injectables Value Growth 2015-2020 ($ Millions)
Figure 79. Russia Sustained Release Injectables Consumption Growth 2015-2020 (K Units)
Figure 80. Russia Sustained Release Injectables Value Growth 2015-2020 ($ Millions)
Figure 81. Middle East & Africa Sustained Release Injectables Consumption Market Share by Countries in 2019
Figure 82. Middle East & Africa Sustained Release Injectables Value Market Share by Countries in 2019
Figure 83. Middle East & Africa Sustained Release Injectables Consumption Market Share by Type in 2019
Figure 84. Middle East & Africa Sustained Release Injectables Consumption Market Share by Application in 2019
Figure 85. Egypt Sustained Release Injectables Consumption Growth 2015-2020 (K Units)
Figure 86. Egypt Sustained Release Injectables Value Growth 2015-2020 ($ Millions)
Figure 87. South Africa Sustained Release Injectables Consumption Growth 2015-2020 (K Units)
Figure 88. South Africa Sustained Release Injectables Value Growth 2015-2020 ($ Millions)
Figure 89. Israel Sustained Release Injectables Consumption Growth 2015-2020 (K Units)
Figure 90. Israel Sustained Release Injectables Value Growth 2015-2020 ($ Millions)
Figure 91. Turkey Sustained Release Injectables Consumption Growth 2015-2020 (K Units)
Figure 92. Turkey Sustained Release Injectables Value Growth 2015-2020 ($ Millions)
Figure 93. GCC Countries Sustained Release Injectables Consumption Growth 2015-2020 (K Units)
Figure 94. GCC Countries Sustained Release Injectables Value Growth 2015-2020 ($ Millions)
Figure 95. Global Sustained Release Injectables Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 96. Global Sustained Release Injectables Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 97. Americas Sustained Release Injectables Consumption 2021-2025 (K Units)
Figure 98. Americas Sustained Release Injectables Value 2021-2025 ($ Millions)
Figure 99. APAC Sustained Release Injectables Consumption 2021-2025 (K Units)
Figure 100. APAC Sustained Release Injectables Value 2021-2025 ($ Millions)
Figure 101. Europe Sustained Release Injectables Consumption 2021-2025 (K Units)
Figure 102. Europe Sustained Release Injectables Value 2021-2025 ($ Millions)
Figure 103. Middle East & Africa Sustained Release Injectables Consumption 2021-2025 (K Units)
Figure 104. Middle East & Africa Sustained Release Injectables Value 2021-2025 ($ Millions)
Figure 105. United States Sustained Release Injectables Consumption 2021-2025 (K Units)
Figure 106. United States Sustained Release Injectables Value 2021-2025 ($ Millions)
Figure 107. Canada Sustained Release Injectables Consumption 2021-2025 (K Units)
Figure 108. Canada Sustained Release Injectables Value 2021-2025 ($ Millions)
Figure 109. Mexico Sustained Release Injectables Consumption 2021-2025 (K Units)
Figure 110. Mexico Sustained Release Injectables Value 2021-2025 ($ Millions)
Figure 111. Brazil Sustained Release Injectables Consumption 2021-2025 (K Units)
Figure 112. Brazil Sustained Release Injectables Value 2021-2025 ($ Millions)
Figure 113. China Sustained Release Injectables Consumption 2021-2025 (K Units)
Figure 114. China Sustained Release Injectables Value 2021-2025 ($ Millions)
Figure 115. Japan Sustained Release Injectables Consumption 2021-2025 (K Units)
Figure 116. Japan Sustained Release Injectables Value 2021-2025 ($ Millions)
Figure 117. Korea Sustained Release Injectables Consumption 2021-2025 (K Units)
Figure 118. Korea Sustained Release Injectables Value 2021-2025 ($ Millions)
Figure 119. Southeast Asia Sustained Release Injectables Consumption 2021-2025 (K Units)
Figure 120. Southeast Asia Sustained Release Injectables Value 2021-2025 ($ Millions)
Figure 121. India Sustained Release Injectables Consumption 2021-2025 (K Units)
Figure 122. India Sustained Release Injectables Value 2021-2025 ($ Millions)
Figure 123. Australia Sustained Release Injectables Consumption 2021-2025 (K Units)
Figure 124. Australia Sustained Release Injectables Value 2021-2025 ($ Millions)
Figure 125. Germany Sustained Release Injectables Consumption 2021-2025 (K Units)
Figure 126. Germany Sustained Release Injectables Value 2021-2025 ($ Millions)
Figure 127. France Sustained Release Injectables Consumption 2021-2025 (K Units)
Figure 128. France Sustained Release Injectables Value 2021-2025 ($ Millions)
Figure 129. UK Sustained Release Injectables Consumption 2021-2025 (K Units)
Figure 130. UK Sustained Release Injectables Value 2021-2025 ($ Millions)
Figure 131. Italy Sustained Release Injectables Consumption 2021-2025 (K Units)
Figure 132. Italy Sustained Release Injectables Value 2021-2025 ($ Millions)
Figure 133. Russia Sustained Release Injectables Consumption 2021-2025 (K Units)
Figure 134. Russia Sustained Release Injectables Value 2021-2025 ($ Millions)
Figure 135. Spain Sustained Release Injectables Consumption 2021-2025 (K Units)
Figure 136. Spain Sustained Release Injectables Value 2021-2025 ($ Millions)
Figure 137. Egypt Sustained Release Injectables Consumption 2021-2025 (K Units)
Figure 138. Egypt Sustained Release Injectables Value 2021-2025 ($ Millions)
Figure 139. South Africa Sustained Release Injectables Consumption 2021-2025 (K Units)
Figure 140. South Africa Sustained Release Injectables Value 2021-2025 ($ Millions)
Figure 141. Israel Sustained Release Injectables Consumption 2021-2025 (K Units)
Figure 142. Israel Sustained Release Injectables Value 2021-2025 ($ Millions)
Figure 143. Turkey Sustained Release Injectables Consumption 2021-2025 (K Units)
Figure 144. Turkey Sustained Release Injectables Value 2021-2025 ($ Millions)
Figure 145. GCC Countries Sustained Release Injectables Consumption 2021-2025 (K Units)
Figure 146. GCC Countries Sustained Release Injectables Value 2021-2025 ($ Millions)
Figure 147. AstraZeneca Sustained Release Injectables Market Share (2018-2020)
Figure 148. Critical Pharmaceuticals Sustained Release Injectables Market Share (2018-2020)
Figure 149. Eli Lilly Sustained Release Injectables Market Share (2018-2020)
Figure 150. Roche Sustained Release Injectables Market Share (2018-2020)
Figure 151. Novartis Sustained Release Injectables Market Share (2018-2020)
Figure 152. Sanofi Sustained Release Injectables Market Share (2018-2020)
Figure 153. Biomarin Sustained Release Injectables Market Share (2018-2020)
Figure 154. Aurobindo Sustained Release Injectables Market Share (2018-2020)
Figure 155. Camurus Sustained Release Injectables Market Share (2018-2020)
Figure 156. Avadel Sustained Release Injectables Market Share (2018-2020)
Figure 157. Alkermes Sustained Release Injectables Market Share (2018-2020)
Figure 158. Taiwan Liposome Company Sustained Release Injectables Market Share (2018-2020)
Figure 159. Ascendis Pharma Sustained Release Injectables Market Share (2018-2020)
Figure 160. Amylin Sustained Release Injectables Market Share (2018-2020)
